FTDD

We “follow the drug money” and expose Ohio organizations and individuals, including doctors, high officials in state government and patient advocacy groups, who have developed cozy financial ties with the hugely profitable drug industry.

Some of these people and groups are the drug industry’s top paid mercenaries, giving a veneer of respectability to what is just a naked attempt by Big Pharma to protect its profiteering and obscene profits.

doctors

FOLLOW THE DRUG DOLLARS: DOCTORS

15 OHIO DOCTORS WHO MAKE A SWEET LIVING AS DRUG INDUSTRY PITCHMEN

Meanwhile Ohioans Struggle to Pay for Rising Drug Prices

COLUMBUS – Public records show dozens of Ohio doctors during 2016 were each paid hundreds of thousands of dollars by drug companies to moonlight as virtual salespersons for the companies’ overpriced drugs. The same companies also paid for hundreds of meals, drinks, hotel rooms and air plane tickets for these doctors.

As spokesman for Issue 2, the November 2017 Ohio ballot measure to lower drug prices, said voters need to be aware of how much money the drug industry spends to influence the medical community.

READ MORE

 

news

FOLLOW THE DRUG DOLLARS: BREAKING NEWS

ISSUE 2 SUPPORTERS DENOUNCE OPPONENTS FOR WAGING SECRETIVE CAMPAIGN

Columbus –The Yes on Issue 2 spokesman today accused the drug companies of running a secretive campaign to defeat Issue 2, the measure on the November ballot to put the brakes on skyrocketing drug prices.

READ MORE

ISSUE 2 FILES COMPLAINT TO REVEAL WHO’S FUNDING ITS OPPONENT

Columbus, Aug. 2, 2017 – The Yes on Issue 2 campaign today filed an official complaint demanding that opponents of their measure be forced to drop their secretive shell game and publicly disclose the names of the drug companies that are financing the fight against Issue 2, the measure on the November ballot to put the brakes on skyrocketing drug prices.

READ MORE

OHIO DOCTORS RAKE IN BIG BUCKS PARTNERING WITH OPIATE DRUG-MAKERSS

Columbus – Dr. Riad Laham, a Cleveland physician, fired off a letter to the Food & Drug Administration (FDA) in 2012 defending the use of opioid-based drugs to deal with his patients’ pains and criticizing medical colleagues who were concerned the over-prescription of such drugs was fueling Ohio’s increasingly deadly opioid epidemic.

READ MORE

37 MEGA DRUG COMPANIES FUND NO ON ISSUE 2 CAMPAIGN

Columbus, Aug. 4, 2017 – With the opponents of Issue 2 keeping Ohio in the dark about who is bankrolling their campaign, supporters of the November ballot measure Friday released the names of 37 drug companies that belong to the industry trade group opposing Issue 2.

READ MORE

lawbreakers-bankroll-no-on-sixone

FOLLOW THE DRUG DOLLARS: DRUG COMPANY FINES

Drug companies have a problem following the law. Now those same companies are bankrolling the opposition to Issue 2.

COMPANY
AND
YEAR

Pfizer, Inc. (2004, 2009, 2012, 2013, 2016)**

GlaxoSmithKline (2005, 2010 and 2012)

Johnson & Johnson (2013)

Abbott Laboratories (Abbvie Inc.) (2012)

Eli Lilly and Co. (2009)

AstraZeneca Pharmaceuticals, LP (2003 and 2010)

Amgen Inc. (2012)

EMD Serono, Inc. (2005)

Merck & Co., Inc. (2008)

Purdue Pharma, LP (2007)***

Allergan, PLC (2010)

Bristol-Myers Squibb Co. (2007)

Novartis Pharmaceuticals Corp. (2010)

Bayer Corp. (2001 and 2003)

Sanofi-Aventis U.S., LLC (2009 and 2012)

Boehringer Ingelheim Pharmaceuticals, Inc. (2012)

Daiichi Sankyo, Inc. (2015)

Novo Nordisk, Inc. (2011 and 2011)

Eisai, Inc. (2010)

Astellas Pharma US, Inc. (2014)

Mallinckrodt Pharmaceuticals (2013)

Biogen (2015)

TOTAL

SETTLEMENTS/FINES FOR VIOLATING FEDERAL LAWS*

$4.1 Billion

$4 Billion

$2.2 Billion

$1.5 Billion

$1.4 Billion

$875 Million

$762 Million

$704 Million

$650 Million

$634.5 Million

$600 Million

$515 Million

$423 Million

$271 Million

$204.5 Million

$95 Million

$39 Million

$28 Million

$11 Million

$7.3 Million

$3.5 Million

$1.5 Million

$19.02 Billion

CONTRIBUTIONS TO NO ON 61 CAMPAIGN (AS OF 6/24/16)

$5,860,000

$2,880,000

$5,860,000

$4,265,000

$2,880,000

$4,265,000

$4,265,000

$385,000

$5,860,000

$1,105,000

$2,880,000

$2,880,000

$2,880,000

$1,150,000

$4,265,00

$1,105,000

$385,000

$2,880,000

$385,000

$1,105,000

$385,000

$2,880,000

$56,540,000

(source: US Department of Justice)